The CEO of China's smartphone Brand 'Honor' Dreams of the day they'll Overtake Apple's iPhone in his Country
Google Files a Patent for a Smart Footwear System that is reminiscent of Apple's Nike + iPod System though more advanced

A California Jury is now deliberating on whether Apple infringed Masimo's smartwatch technology

1 cover Blood Oxygen sensor lawsuit

This week a federal judge in Santa Ana, California, dismissed business and marketing claims against Apple that amounted to $1.85 Billion at the end of a three-week trial, according to Bloomberg.

This now leaves the jury to decide only if Apple improperly used trade secrets related to a blood-oxygen monitoring sensor used in its Apple Watch since the introduction of the Apple Watch series 6 in 2020.  Masimo was seeking $3.1 Billion. A verdict is likely to be reached this week.

Apple and Masimo have been in litigation relating to health related technologies for smartwatches for years. Original meetings between the two companies regarding Masimo's technology dates back a decade. We posted an in-depth report back in January 2020 covering Masimo's original lawsuit against Apple.

In October 2022 Patently Apple covered Apple suing Masimo for infringing 4 Apple Watch design patents. One of the exhibits from that lawsuit is presented below.    2 apple watch allegedly copied by Masimo
2 apple watch allegedly copied by Masimo


The comments to this entry are closed.